Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells. - Wikidata - awgldk - TriplyDB

Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells.

Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells.

http://www.wikidata.org/entity/Q33772145

about

Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells B cells in chronic graft-versus-host disease A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy Tumor cell lysates as immunogenic sources for cancer vaccine design NKG2D Ligands in Tumor Immunity: Two Sides of a Coin Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens.Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells Recruiting dendritic cells to improve antibody therapy of cancer High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Engineered antibody Fc variants with enhanced effector function.Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice.Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus Polymeric human Fc-fusion proteins with modified effector functions.Role of chaperones and FcgammaR in immunogenic death.Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction.In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal Glycolipids.Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.Interactions of tumor cells with dendritic cells: balancing immunity and tolerance Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.Monoclonal antibodies for cancer immunotherapy.In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells.Association of MICA-TM and MICB C1_2_A microsatellite polymorphisms with tumor progression in patients with colorectal cancer.Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.FcγRIIB: a modulator of cell activation and humoral tolerance.Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity.Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.CTL induction by cross-priming is restricted to immunodominant epitopes.Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer.

P2860

Q24648424-4A03DC0A-7451-4921-82C5-FE4C86CFF4C4 Q26861706-D2746617-497C-4F8E-96B6-D77D383E9A14 Q27314576-700C63CE-A693-4746-9251-E54A62C6AE44 Q28083469-260AE468-2697-4AB7-BF91-A1CEB8958430 Q28083832-10372878-4CC3-4BE9-9975-59EB6CFBD056 Q30416502-62FF2197-C1F5-483B-8CD2-0653792CE020 Q33504695-527C33BC-2AAF-424A-9DBC-4BE9BDB0AE48 Q33584637-56F86EDB-F58C-4F26-ADD0-1D416E7C8048 Q33758468-A9EA39A8-67C9-4C09-B1AA-E3B78F1D7884 Q33772194-5A9ECCCB-F6C5-4A80-A321-A9EE3D94274E Q34135089-BEBB401E-C277-4C38-A6C1-698B65469F12 Q34424958-5599FB49-B1AC-4E5D-9DEE-6DA3BF60703A Q34694955-387C90F1-C96D-4FDC-B9DC-EFECB55A1B61 Q35157425-4C78A7BC-A881-40EE-BF3C-C5888D54B4AB Q35173733-03BCEDCE-C985-452C-BC03-642889C78363 Q35551564-58460142-3EE7-44D2-BBBD-259B29F3237E Q35575030-7B9A0249-2FBF-4211-92EE-2FDC22D0B850 Q35579313-5ABE6266-1CE2-4F4B-88A6-4C4CCBA325B9 Q36331013-76BE58D4-22EE-49EE-910C-76D065BDE649 Q36407174-012652C5-3120-4EF8-977A-4AC472CDD204 Q36446189-DA5CB692-7A08-4EFB-8A47-DDBC2B067930 Q36975749-3E6997E6-2AC7-4682-9D68-D7F4D059F692 Q37118186-24A59BD7-42F9-42D6-B353-48350CE85B3B Q37181031-BA272CA8-3946-4BC1-AC21-2E8284AC5E7B Q37220754-342A1462-5B28-46EC-9DAE-E66B89249CFE Q37241707-82A00860-8F0E-48D0-99DC-74B7814492C4 Q37721591-A6927DC5-3006-4DBF-902A-6B43081F542B Q37863518-712DD098-1C3D-4226-AB76-306FEBBE635F Q37990547-0DAF2D99-8BE3-45E0-A0E1-3013E00842C4 Q38356968-A9F3DAC4-266F-4FDB-B58F-B7F25DFD01B3 Q38860610-CEB10863-A6D4-4B8E-A679-D030463A1604 Q39888117-1D33EDEE-A969-4DC9-AFAE-77578A8E338D Q45369927-D2FA7AA7-822A-4CFB-BF75-A7DA87D935E1 Q53620715-4FB7C4FE-AD39-4E5D-B028-55536BEA07D9 Q55006981-4BDB2092-6C26-4762-B684-D9FD6271C0D2

P2860

Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells.

http://www.wikidata.org/entity/Q33772145

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Efficient cross-priming of tum ...... ti-MICA opsonized tumor cells.

@ast

Efficient cross-priming of tum ...... ti-MICA opsonized tumor cells.

@en

type

label

Efficient cross-priming of tum ...... ti-MICA opsonized tumor cells.

@ast

Efficient cross-priming of tum ...... ti-MICA opsonized tumor cells.

@en

prefLabel

Efficient cross-priming of tum ...... ti-MICA opsonized tumor cells.

@ast

Efficient cross-priming of tum ...... ti-MICA opsonized tumor cells.

@en

P1433

Q33772145-1631CF0E-46A6-4BE1-B451-B34B512F2C80

P1476

Q33772145-8F966F57-FD11-4363-8EE7-0DECBD013924

P2093

Q33772145-04AD271F-0228-4DEF-9B4D-B5A5FD73E30A

Q33772145-0B496F26-C445-482B-99F7-1EB206F9CF2F

Q33772145-12359EE3-787D-4BD5-8322-CD2AF2278C7E

Q33772145-17F24A02-F898-49AB-87B2-5D510E72D14C

Q33772145-1FE9CCFA-CD8C-4F51-9890-6FB84EF983CD

Q33772145-6D662DCA-5F82-4EE4-8DD3-B3118A1C2777

Q33772145-D06C31F8-7F59-4A8D-A8AA-D6CEA1BC8884

Q33772145-F9905A9D-AA9F-4672-B98E-51A95DEB56CF

P2860

Q33772145-160C8E18-4706-4AB6-BF3E-0FB5ADAB6E8E

Q33772145-167B8B72-AB64-4B90-9CC3-726AF9850906

Q33772145-178B49EA-C040-408B-A488-1BF210700F70

Q33772145-1F1728E5-9E69-43CC-8CDE-45E235C69A0E

Q33772145-2049CDFE-EE6D-4B35-9588-2B0BF9E1183F

Q33772145-487D2A72-9DF0-4A39-8DD2-4834B7E9BF56

Q33772145-4AD8F8FF-6537-4D4D-8B6B-BA98F3A768DE

Q33772145-56355049-7EA4-41A0-9656-E843C9FE306A

Q33772145-6445780D-3084-4102-A113-2A74618C8353

Q33772145-67F3F975-1360-461F-9CC7-53AE354666F5

P304

Q33772145-FEF62490-CD71-4599-9E8B-FFBAD9D20764

P31

Q33772145-05190C57-76E8-4BF3-8BD6-DAA4513673FC

P356

Q33772145-B917BC4A-EE6F-4AF6-8D5E-EBF86EC86FD5

P407

Q33772145-8E1737F2-04D5-4C7F-97AF-F81576308F6A

P433

Q33772145-C1CD7DAA-CC44-4F3A-B26E-26047C18C5EE

P478

Q33772145-22B31E6F-4483-42BD-9B86-8EFCB19E4F06

P577

Q33772145-ED4321BB-FACB-47DF-84B4-95E341CD1D31

P5875

Q33772145-1AC0AFCE-05F8-4913-8A85-D0E731A7A0C5

P698

Q33772145-CCE4FF1F-9F32-409C-8C2C-B2EB27AFB8B5

P932

Q33772145-8C0D8BE1-BB48-44E0-9A07-609D0A2F8332

P356

PNAS.0501953102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Efficient cross-priming of tum ...... ti-MICA opsonized tumor cells.

@en

P2093

Cassian Yee

http://www.w3.org/2001/XMLSchema#string

Daniel Cioca

http://www.w3.org/2001/XMLSchema#string

Naomi N Hunder

http://www.w3.org/2001/XMLSchema#string

Stanley R Riddell

http://www.w3.org/2001/XMLSchema#string

Thomas Spies

http://www.w3.org/2001/XMLSchema#string

Veronika Groh

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Yongqing Q Li

http://www.w3.org/2001/XMLSchema#string

P2860

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

Phenotypic analysis of antigen-specific T lymphocytes

Dendritic cells: specialized and regulated antigen processing machines

Molecular identification of a danger signal that alerts the immune system to dying cells

P304

6461-6466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0501953102

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7913215

http://www.w3.org/2001/XMLSchema#string

P698

15824323

http://www.w3.org/2001/XMLSchema#string

P932

1088382

http://www.w3.org/2001/XMLSchema#string